Enabled/vasodilator-stimulated phosphoprotein (Ena/VASP) proteins are key actin regulators that localize at regions of dynamic actin remodeling, including cellular protrusions and cell–cell and cell–matrix junctions. Several studies have suggested that Ena/VASP proteins are involved in the formation and function of cellular junctions. Here, we establish the importance of Ena/VASP in endothelial junctions in vivo by analysis of Ena/VASP-deficient animals. In the absence of Ena/VASP, the vasculature exhibits patterning defects and lacks structural integrity, leading to edema, hemorrhaging, and late stage embryonic lethality. In endothelial cells, we find that Ena/VASP activity is required for normal F-actin content, actomyosin contractility, and proper response to shear stress. These findings demonstrate that Ena/VASP is critical for actin cytoskeleton remodeling events involved in the maintenance of functional endothelia.
Ena/VASP is required for endothelial barrier function in vivo
C. Furman's present address is Pfizer Research Technology Center, Cambridge, MA 02139.
A.V. Kwiatkowski's present address is Dept. of Biological Sciences, Stanford University, Stanford, CA 94305.
Abbreviations used in this paper: E, embryonic day; Ena/VASP, Enabled/vasodilator-stimulated phosphoprotein; HUVEC, human umbilical vein endothelial cell; Mena, mammalian Ena; MLC, myosin light chain; PECAM, platelet/endothelial cell adhesion molecule; VE-cadherin, vascular endothelial–cadherin; ZO, zonula occludens.
Craig Furman, Alisha L. Sieminski, Adam V. Kwiatkowski, Douglas A. Rubinson, Eliza Vasile, Roderick T. Bronson, Reinhard Fässler, Frank B. Gertler; Ena/VASP is required for endothelial barrier function in vivo . J Cell Biol 19 November 2007; 179 (4): 761–775. doi: https://doi.org/10.1083/jcb.200705002
Download citation file:
Sign in
Client Account
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement
Advertisement